{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T16:21:31Z","timestamp":1787761291929,"version":"build-2784847793"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,12]]},"abstract":"\n Purpose:<\/jats:title>\n This study aimed to compare the clinical efficacy and prognostic analysis results of 8spheres polyvinyl alcohol (PVA) microspheres (8SM) with gelatin sponge (GS) particles for transcatheter arterial chemoembolization (TACE) in patients with stages A\u2013B hepatocellular carcinoma (HCC).<\/jats:p>\n <\/jats:sec>\n \n Methods:<\/jats:title>\n \n Data were collected from 172 patients who underwent TACE at Harbin Medical University Cancer Hospital from January 2014 to July 2020. Patients were divided into two groups: TACE group using 8SM plus lipiodol (8spheres PVA group,\n N<\/jats:italic>\n = 89) and TACE group using GS particles plus lipiodol (the GS group,\n N<\/jats:italic>\n = 83). Subsequently, we compared the liver function, blood count, alpha-fetoprotein (AFP), and other parameters of patients in each group before and after interventional embolization. We also calculated the patient's progression-free survival and overall survival in these groups.\n <\/jats:p>\n <\/jats:sec>\n \n Results:<\/jats:title>\n \n The postoperative liver function indices, such as alanine aminotransferase (ALT) and aspartate aminotransferase (AST) in the 8spheres PVA group, were worse than in the GS group. The postoperative median survival time was 19 \u00b1 3.06 months and no significant difference in survival time was observed in GS group (26 \u00b1 3.19 months) (\n P<\/jats:italic>\n = 0.509). Multivariate analysis showed that targeted therapy (\n P<\/jats:italic>\n = 0.051), maximum tumor diameter <5 cm (\n P<\/jats:italic>\n = 0.018), age \u226560 years (\n P<\/jats:italic>\n = 0.018), and AFP <120.5 \u03bcg\/L (\n P<\/jats:italic>\n = 0.007) significantly improved the overall survival rate of patients.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusion:<\/jats:title>\n Postoperative liver function indices of patients with HCC treated with GS particles were better than those treated with 8SM; thus, GS particles are more suitable for patients with poor liver function.<\/jats:p>\n <\/jats:sec>","DOI":"10.4103\/jcrt.jcrt_736_22","type":"journal-article","created":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T08:09:18Z","timestamp":1673424558000},"page":"1981-1987","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Comparison of 8spheres polyvinyl alcohol microsphere and gelatin sponge particle efficacy for transcatheter arterial chemoembolization in stages A to B patients with hepatocellular carcinoma"],"prefix":"10.4103","volume":"18","author":[{"given":"Jia","family":"Zeng","sequence":"first","affiliation":[{"name":"Department of Cancer Hospital Affiliated to Harbin Medical University, Harbin, Heilongjiang Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufeng","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Cancer Hospital Affiliated to Harbin Medical University, Harbin, Heilongjiang Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiwen","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Interventional Radiology, Cancer Hospital Affiliated to Harbin Medical University, Harbin, Heilongjiang Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingwen","family":"Hou","sequence":"additional","affiliation":[{"name":"Department of Interventional Radiology, Cancer Hospital Affiliated to Harbin Medical University, Harbin, Heilongjiang Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongfeng","family":"He","sequence":"additional","affiliation":[{"name":"Department of Interventional Radiology, Cancer Hospital Affiliated to Harbin Medical University, Harbin, Heilongjiang Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,1,11]]},"reference":[{"key":"R1-20250514","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"R2-20250514","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1016\/S0140-6736(02)08649-X","article-title":"Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: A randomised controlled trial","volume":"359","author":"Llovet","year":"2002","journal-title":"Lancet"},{"key":"R3-20250514","doi-asserted-by":"crossref","first-page":"733","DOI":"10.4103\/jcrt.JCRT_1848_20","article-title":"Short-term efficacy and safety of callispheres drug-loaded microsphere embolization in primary hepatocellular carcinoma","volume":"17","author":"Li","year":"2021","journal-title":"J Cancer Res Ther"},{"key":"R4-20250514","doi-asserted-by":"crossref","first-page":"323","DOI":"10.5152\/dir.2014.13462","article-title":"The effect of using different embolic agents on survival in transarterial chemoembolization of hepatocellular carcinoma: Gelfoam versus polyvinyl alcohol","volume":"20","author":"Ko\u00e7yi\u011fit","year":"2014","journal-title":"Diagn Interv Radiol"},{"key":"R5-20250514","doi-asserted-by":"crossref","first-page":"767","DOI":"10.4103\/jcrt.JCRT_297_17","article-title":"Transarterial chemoembolization with gelatin sponge microparticles for barcelona clinic liver cancer Stage C and large hepatocellular carcinoma: Initial clinical experience","volume":"13","author":"Zhou","year":"2017","journal-title":"J Cancer Res Ther"},{"key":"R6-20250514","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1148\/radiographics.14.3.8066276","article-title":"Embolotherapy: Agents, clinical applications, and techniques","volume":"14","author":"Coldwell","year":"1994","journal-title":"Radiographics"},{"key":"R7-20250514","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1080\/13645706.2018.1432489","article-title":"Transvascular therapy of Hepatocellular Carcinoma (HCC), status and developments","volume":"27","author":"Gnutzmann","year":"2018","journal-title":"Minim Invasive Ther Allied Technol"},{"key":"R8-20250514","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1055\/s-0030-1247132","article-title":"Modified RECIST (mRECIST) assessment for hepatocellular carcinoma","volume":"30","author":"Lencioni","year":"2010","journal-title":"Semin Liver Dis"},{"key":"R9-20250514","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1159\/000509424","article-title":"Guidelines for the diagnosis and treatment of hepatocellular carcinoma (2019 Edition)","volume":"9","author":"Zhou","year":"2020","journal-title":"Liver Cancer"},{"key":"R10-20250514","doi-asserted-by":"crossref","first-page":"e10832.","DOI":"10.1097\/MD.0000000000010832","article-title":"Transarterial chemoembolization for unresectable hepatocellular carcinoma: A comparison of the efficacy and safety of 2 embolic agents","volume":"97","author":"Chen","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"R11-20250514","first-page":"237","article-title":"Transarterial chemoembolization by using callispheres drug-eluting beads combined with 8Spheres microsphere for the treatment of advanced hepatocellular carcinoma: Study on its short-term efficacy and safety","volume":"28","author":"Cun","year":"2019","journal-title":"J Interv Radiol"},{"issue":"Suppl 2","key":"R12-20250514","first-page":"e49","article-title":"Arterial embolization of massive hepatocellular carcinoma with lipiodol and gelatin sponge","volume":"51","author":"Xie","year":"2015","journal-title":"Indian J Cancer"},{"key":"R13-20250514","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1097\/01.RVI.0000182160.26798.A2","article-title":"Hepatic arterial chemoembolization for hepatocellular carcinoma: Comparison of survival rates with different embolic agents","volume":"16","author":"Brown","year":"2005","journal-title":"J Vasc Interv Radiol"},{"key":"R14-20250514","first-page":"531","article-title":"TACE by using microspheres and lipiodol for the treatment of hepatocellular carcinoma: Analysis of short-term efficacy","volume":"26","author":"You","year":"2017","journal-title":"J Interv Radiol"},{"key":"R15-20250514","doi-asserted-by":"crossref","first-page":"10905","DOI":"10.1007\/s13277-014-2408-9","article-title":"Pharmacokinetics of gelatin sponge microparticles in a rabbit VX2 liver tumor model of hepatic arterial chemoembolization","volume":"35","author":"Zhang","year":"2014","journal-title":"Tumour Biol"},{"key":"R16-20250514","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jhep.2018.03.019","article-title":"EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma","volume":"69","year":"2018","journal-title":"J Hepatol"},{"key":"R17-20250514","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.2217\/fon-2018-0136","article-title":"DEB-TACE: A standard review","volume":"14","author":"Melchiorre","year":"2018","journal-title":"Future Oncol"},{"key":"R18-20250514","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/s11547-019-01093-x","article-title":"Degradable starch microspheres transarterial chemoembolization (DSMs-TACE) in patients with unresectable hepatocellular carcinoma (HCC): Long-term results from a single-center 137-patient cohort prospective study","volume":"125","author":"Orlacchio","year":"2020","journal-title":"Radiol Med"},{"key":"R19-20250514","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1016\/j.ejrad.2011.05.004","article-title":"Histopathologic correlation of hepatocellular carcinoma after transcatheter arterial chemoembolization with polyvinyl alcohol particle of various sizes","volume":"81","author":"Lee","year":"2012","journal-title":"Eur J Radiol"},{"key":"R20-20250514","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1111\/j.1349-7006.2008.00909.x","article-title":"Association between increment of serum VEGF level and prognosis after transcatheter arterial chemoembolization in hepatocellular carcinoma patients","volume":"99","author":"Shim","year":"2008","journal-title":"Cancer Sci"},{"key":"R21-20250514","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s12072-021-10184-9","article-title":"Lenvatinib in combination with transarterial chemoembolization for treatment of unresectable hepatocellular carcinoma (uHCC): A retrospective controlled study","volume":"15","author":"Fu","year":"2021","journal-title":"Hepatol Int"},{"key":"R22-20250514","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.4103\/jcrt.JCRT_801_19","article-title":"Transarterial chemoembolization combined with apatinib versus transarterial chemoembolization alone for hepatocellular carcinoma with macroscopic vascular invasion: A propensity score matching analysis","volume":"16","author":"Shen","year":"2020","journal-title":"J Cancer Res Ther"}],"container-title":["Journal of Cancer Research and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.jcrt_736_22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T15:31:56Z","timestamp":1787758316000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.jcrt_736_22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":22,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.4103\/jcrt.jcrt_736_22","relation":{},"ISSN":["0973-1482","1998-4138"],"issn-type":[{"value":"0973-1482","type":"print"},{"value":"1998-4138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"2022-04-04","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-08-07","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}